摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(4-methoxy-phenyl)-1,4-dioxa-spiro[4.5]decane-8-carboxylic acid | 56327-04-9

中文名称
——
中文别名
——
英文名称
8-(4-methoxy-phenyl)-1,4-dioxa-spiro[4.5]decane-8-carboxylic acid
英文别名
4-carboxy-4-(p-anisyl)cyclohexanone, ethylene ketal;4-carboxy-4-(4-methoxyphenyl)cyclohexanone, ethylene ketal;1,4-Dioxaspiro[4.5]decane-8-carboxylic acid, 8-(4-methoxyphenyl)-;8-(4-methoxyphenyl)-1,4-dioxaspiro[4.5]decane-8-carboxylic acid
8-(4-methoxy-phenyl)-1,4-dioxa-spiro[4.5]decane-8-carboxylic acid化学式
CAS
56327-04-9
化学式
C16H20O5
mdl
——
分子量
292.332
InChiKey
KGVYVZCZKIDIBH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    154-155.5 °C(Solv: dichloromethane (75-09-2))
  • 沸点:
    470.0±45.0 °C(Predicted)
  • 密度:
    1.27±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:3f913c8eb22ca169eb437e731dda5b9f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    4-Amino-4-arylcyclohexanones and their derivatives, a novel class of analgesics. 1. Modification of the aryl ring
    摘要:
    Investigation of central nervous system activity of phenylcyclohexylamines was continued by preparation of "reversed" analogues. Following the unexpected finding of analgesic activity with 1-(dimethylamino)-1-phenylcyclohexylamine, the SAR of the series was investigated. Synthesis starts by double Michael reaction of acrylate on arylacetonitriles. Following cyclization, decarboxylation, ketalization, and saponification, the geminally substituted acid is rearranged to the isocyanate by means of (C6H5O)2PON3. Isocyanates were then converted to the title compounds. Analgesic activity is very sensitive to the nature and position of the substitutent on the aromatic ring. The most potent compounds in this series (p-CH3, p-Br) showed 50% the potency of morphine. Deletion of the ring oxygen abolishes activity.
    DOI:
    10.1021/jm00178a014
  • 作为产物:
    描述:
    8-(4-methoxy-phenyl)-1,4-dioxa-spiro[4.5]decane-8-carbonitrile乙二醇氢氧化钾 作用下, 以 异丙醇 为溶剂, 以245 parts (83.8%)的产率得到8-(4-methoxy-phenyl)-1,4-dioxa-spiro[4.5]decane-8-carboxylic acid
    参考文献:
    名称:
    1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and
    摘要:
    新颖的化合物1-[1-(4-芳基-环己基)-4-哌啶基]-1,3-二氢-2H-苯并咪唑-2-酮和1-芳基-8-(4-芳基-环己基)-1,3,8-三氮杂螺[4,5]癸烷-4-酮,可用作抗恶心和抗精神病药物。
    公开号:
    US04329353A1
点击查看最新优质反应信息

文献信息

  • 4-Arylcyclohexylamines
    申请人:The Upjohn Company
    公开号:US03979444A1
    公开(公告)日:1976-09-07
    The invention relates to novel 4-hydroxymethyl(acyloxymethyl and methyl)-4-arylcyclohexylamines embraced by the formula ##SPC1## Wherein Ar is an aromatic ring selected from the group consisting of phenyl and naphthyl, each of which has from zero through three substituents independently selected from the group consisting of fluorine, chlorine, bromine, lower alkyl of one through three carbon atoms, lower alkoxy of one through three carbon atoms, and lower alkylthio of one through three carbon atoms; Z is selected from the group consisting of hydrogen, hydroxy and lower acyloxy of one through four carbon atoms; .about. is a generic expression denoting cis and trans stereoconfiguration and mixtures thereof, with the proviso that when the stereoconfiguration of the linkage connecting the cyclohexane ring and CH.sub.2 Z is cis to the amino group, the linkage connecting the cyclohexane and Ar rings is trans, and vice versa; R.sup.1 is selected from the group consisting of hydrogen and lower alkyl of one through three carbon atoms; R.sup.2 is selected from the group consisting of hydrogen, lower alkyl of one through three carbon atoms, ##EQU1## WHEREIN N IS 2 THROUGH 5 AND Ar has the same meaning as above; R.sup.1 and R.sup.2 taken together with --N< is a saturated heterocyclic amino radical selected from the group consisting of unsubstituted and substituted pyrrolidino, piperidino, hexamethylenimino, morpholino and piperazino; and pharmacologically acceptable acid addition salts thereof. It also relates to intermediates and processes for the preparation of the aforesaid novel compounds (I) and novel derivatives thereof. The administration to humans and animals of the novel compounds (I) depresses their central nervous systems and lowers their blood pressures.
    该发明涉及一种新型4-羟甲基(酰氧甲基和甲基)-4-芳基环己胺,其化学式如下:其中Ar是从苯基和基中选择的芳香环,每个环上独立选择的取代基包括、1至3个碳原子的低烷基、1至3个碳原子的低烷氧基和1至3个碳原子的低烷基基;Z选择自氢、羟基和1至4个碳原子的低酰氧基;~表示顺式和反式立体构型及其混合物,但当连接环己烷环和CH2Z的立体构型为顺时,连接环己烷环和Ar环的连接是反式,反之亦然;R1选择自氢和1至3个碳原子的低烷基;R2选择自氢、1至3个碳原子的低烷基、其中N为2至5且Ar的含义与上述相同;R1和R2与-N<一起构成从未取代和取代的吡咯啉基、哌啶基、六亚甲基基、吗啉基和哌嗪基中选择的饱和杂环基基团;以及其药理学上可接受的酸盐。它还涉及中间体和用于制备上述新化合物(I)及其新衍生物的过程。将该新型化合物(I)用于人类和动物,可抑制其中枢神经系统并降低其血压。
  • Butyrophenones as hypotensive agents. Derivatives of 4-aryl-4-(hydroxymethyl)cyclohexylamine
    作者:Daniel Lednicer、D. Edward Emmert、Alan D. Rudzik、Boyd E. Graham
    DOI:10.1021/jm00240a014
    日期:1975.6
    preparation of butyrophenone derivatives of 4-aryl-4-(hydroxymethyl)cyclohex-1-ylamines starting from the corresponding 4-cyano-4-phenylcyclohexan-1-ones is described. Substitution was varied with both rings; both isomers of 4-phenyl-4-(hydroxymethyl)cyclohex-1-ylamine were characterized. Those derivatives which carried p-fluoro substitution on the butyrophenone exhibited hypotensive activity in the rat with
    描述了从相应的4-基-4-苯基环己酮-1-酮开始制备4-芳基-4-(羟甲基)环己-1-基胺的丁苯酮衍生物。两个环都有不同的取代基;对4-苯基-4-(羟甲基)环己-1-基胺的两种异构体进行了表征。与缺乏羟甲基的化合物相比,在丁苯酮上进行对取代的那些衍生物在大鼠中表现出降压活性,而CNS活性降低。讨论了取代对4-芳基环的影响。
  • LEDNICER D.; VOIGTLANDER P. F.; EMMERT D. E., J. MED. CHEM., 1980, 23, NO 4, 424-430
    作者:LEDNICER D.、 VOIGTLANDER P. F.、 EMMERT D. E.
    DOI:——
    日期:——
  • LEDNICER D.; EMMERT D. E.; RUDZIK A. D.; GRAHAM B. E., J. MED. CHEM. <JMCM-AR>, 1975, 18, NO 6, 593-599
    作者:LEDNICER D.、 EMMERT D. E.、 RUDZIK A. D.、 GRAHAM B. E.
    DOI:——
    日期:——
  • 1-(4-Aryl-cyclohexyl)piperidine derivatives
    申请人:JANSSEN PHARMACEUTICA N.V.
    公开号:EP0035902B1
    公开(公告)日:1984-10-31
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯